Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC
Background: Home treatment of patients affected by COVID-19 is still a matter of daily debate. During the clinical evolution of the disease, there are high risks of lung failure, which requires oxygen therapy. Here, we report our clinical experience with at-home treatment using high-flow nasal cannu...
Main Authors: | Anna Annunziata, Antonietta Coppola, Novella Carannante, Francesca Simioli, Maurizia Lanza, Pierpaolo Di Micco, Giuseppe Fiorentino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/4/413 |
Similar Items
-
The importance of high flow nasal cannula (HFNC) oxygen therapy
by: TIGLIS Mirela, et al.
Published: (2019-03-01) -
Versatility of Intermittent Abdominal Pressure Ventilation in a Case of Complicated Restrictive Respiratory Failure and COVID-19
by: Francesca Simioli, et al.
Published: (2022-05-01) -
The Effectiveness Of High-Flow Nasal Cannula (HFNC) Therapy On Improvement Of Oxygen Saturation With Acute Breathing Failure In Covid-19 Patients (Literature Study)
by: Syafruddin Ali Salaka, et al.
Published: (2022-04-01) -
Role of high flow nasal cannula (HFNC) for pre-oxygenation among pregnant patients: Current evidence and review of literature
by: Ajay Singh, et al.
Published: (2022-01-01) -
Comparison of CPAP and HFNC in Management of Bronchiolitis in Infants and Young Children
by: Majken Bisgaard Pedersen, et al.
Published: (2017-04-01)